Left ventricular assist device driveline infection and the frequency of dressing change in hospitalized patients

Heart & Lung : the Journal of Critical Care
Lisa WusJohn W C Entwistle

Abstract

To determine if driveline infection is related to dressing change frequency in hospitalized adult patients with newly implanted left ventricular assist devices (LVAD). Guidelines do not exist for the frequency of driveline exit-site dressing change in hospitalized patients resulting in wide variation in practice. A retrospective chart review was conducted on 68 patients implanted with a HeartMate II LVAD between August 2008 and September 2013 at an urban medical center. No driveline infections were found. Frequency of the driveline dressing change varied from daily, three times a week, and weekly. The daily dressing change group was younger in age compared to the weekly group (p = 0.005) and three times a week group (p = 0.001). No other differences were found. Driveline infections do not appear to be related to the frequency of dressing change in this population. Our data and other studies on this topic thus far are too limited to draw definitive conclusions about optimal frequency of dressing change for infection prevention.

References

Jun 25, 2003·The Annals of Thoracic Surgery·William L HolmanJames K Kirklin
Jul 14, 2004·Progress in Cardiovascular Nursing·Elaine BondKarl Nelson
Sep 15, 2005·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Raymond ChinnFrancis Pagani
Jul 24, 2007·The Annals of Thoracic Surgery·Andreas ZiererNader Moazami
Sep 12, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Andrea GarattiVitali Ettore
Oct 28, 2008·Dimensions of Critical Care Nursing : DCCN·Katrina Barnes
Jun 24, 2009·Current Infectious Disease Reports·Shmuel Shoham, Leslie W Miller
Jul 18, 2009·Journal of the American College of Cardiology·Francis D PaganiUNKNOWN HeartMate II Investigators
Apr 24, 2010·Journal of Cardiac Surgery·William L HolmanJames K Kirklin
Dec 17, 2010·Expert Review of Medical Devices·Farooq H Sheikh, Stuart D Russell
May 5, 2011·Scandinavian Cardiovascular Journal : SCJ·Tobias BomholtFinn Gustafsson
Oct 22, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Sameh M HozayenPeter M Eckman
Nov 9, 2011·Cardiology Clinics·Daniel Pereda, John V Conte
May 9, 2012·Current Infectious Disease Reports·Denis Spelman, Donald Esmore
Jul 7, 2012·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Daniel J GoldsteinJames Kirklin
Jul 24, 2012·The Annals of Thoracic Surgery·Vikas SharmaLyle D Joyce
Nov 29, 2012·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·Anne CannonErin Davis
Dec 19, 2012·The Journal of Thoracic and Cardiovascular Surgery·Daniel P MulloyJohn A Kern
Jan 4, 2013·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 15, 2013·Circulation·Rachel J GordonUNKNOWN Ventricular Assist Device Infection Study Group
Feb 4, 2014·Journal of the American College of Cardiology·Prateeti KhazanieAdrian F Hernandez
May 27, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James K KirklinJames B Young
Jul 19, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Christine E KovalEugene Blackstone
Jul 19, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Athanasios TsiourisJeffrey A Morgan

❮ Previous
Next ❯

Citations

Mar 23, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S SiméonP Tattevin
Jul 7, 2018·Current Opinion in Organ Transplantation·Christine Koval
Nov 3, 2017·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·John C O'HoroM Rizwan Sohail
May 15, 2020·Open Forum Infectious Diseases·Radoslav ZinovievNisha A Gilotra
May 18, 2019·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Evgenij V PotapovFinn Gustafsson
May 9, 2021·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Zeliha Ozdemir KokenKadir Caliskan
Sep 15, 2021·The Thoracic and Cardiovascular Surgeon·Kristina KrzeljDavid McGiffin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.